The store will not work correctly when cookies are disabled.
S-2,4-dichlorophenyl 2-(2-(methylsulfonyl)ethylthio)pyridine-3-carbothioate
ID: ALA4530453
PubChem CID: 2821402
Max Phase: Preclinical
Molecular Formula: C15H13Cl2NO3S3
Molecular Weight: 422.38
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CS(=O)(=O)CCSc1ncccc1C(=O)Sc1ccc(Cl)cc1Cl
Standard InChI: InChI=1S/C15H13Cl2NO3S3/c1-24(20,21)8-7-22-14-11(3-2-6-18-14)15(19)23-13-5-4-10(16)9-12(13)17/h2-6,9H,7-8H2,1H3
Standard InChI Key: HQSVVUZNLSRPKQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 25 0 0 0 0 0 0 0 0999 V2000
9.0538 -2.6916 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4705 -3.4082 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.8828 -2.6890 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6191 -5.0665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6180 -5.8938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3327 -6.3067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0492 -5.8933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0464 -5.0628 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3310 -4.6537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3285 -3.8287 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.0417 -3.4141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7574 -3.8245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1862 -3.8202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9046 -4.6541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9044 -3.8292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1902 -5.0668 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.4757 -4.6545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4792 -3.8289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7655 -3.4166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0502 -3.8294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0530 -4.6586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7673 -5.0671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1946 -3.4180 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.3351 -3.4180 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 2 1 0
2 13 1 0
4 14 1 0
14 15 2 0
14 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
18 23 1 0
20 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 422.38 | Molecular Weight (Monoisotopic): 420.9435 | AlogP: 4.46 | #Rotatable Bonds: 6 |
Polar Surface Area: 64.10 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.22 | CX LogP: 3.74 | CX LogD: 3.74 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.64 | Np Likeness Score: -1.65 |
References
1. (2017) Inhibitors of grb2-associated binding protein 1 (gab1) and methods of treating cancer using the same, |